Furthermore, studies characterizing EVs from the urine suggested upregulation of synaptosomal-associated protein 23 (SNAP23) and calbindin along with striking enrichment of endolysosomal proteins in PD patients [77], suggesting the utility of EVs in the urine as an accessible source of biomarker discovery for PD. Here, SNAP23 is linked to Parkinson disease.